Exploring environmental modifiers of LRRK2-associated Parkinson's disease penetrance: An exposomics and metagenomics pilot study on household dust

被引:0
|
作者
Andujar, Begona Talavera [1 ]
Pereira, Sandro L. [1 ]
Busi, Susheel Bhanu [1 ,2 ]
Usnich, Tatiana [3 ]
Borsche, Max [3 ,4 ]
Ertan, Sibel [5 ]
Bauer, Peter [6 ]
Rolfs, Arndt [6 ]
Hezzaz, Soraya [1 ]
Ghelfi, Jenny [1 ]
Brueggemann, Norbert [3 ,4 ]
Antony, Paul [1 ]
Wilmes, Paul [1 ,7 ]
Klein, Christine [3 ]
Gruenewald, Anne [1 ]
Schymanski, Emma L. [1 ]
机构
[1] Univ Luxembourg, Luxembourg Ctr Syst Biomed LCSB, L-4367 Belvaux, Luxembourg
[2] UK Ctr Ecol & Hydrol, Wallingford, Oxon, England
[3] Univ Lubeck, Inst Neurogenet, Lubeck, Germany
[4] Univ Lubeck, Dept Neurol, Lubeck, Germany
[5] Koc Univ, Sch Med, Dept Neurol, Istanbul, Turkiye
[6] CENTOGENE GmbH, Rostock, Germany
[7] Univ Luxembourg, Fac Sci Technol & Med, Dept Life Sci & Med, L-4362 Esch Sur Alzette, Luxembourg
关键词
Indoor environment; Exposomics; Metagenomics; Parkinson's disease; Leucine-rich repeat kinase 2 (LRRK2); Bisphenol S; MASS-SPECTROMETRY; MITOCHONDRIAL DYSFUNCTION; OXIDATIVE STRESS; PIPECOLIC ACID; IN-VITRO; MANAGEMENT; RELEVANCE; FIPRONIL; BACTERIA;
D O I
10.1016/j.envint.2024.109151
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Pathogenic variants in the Leucine-rich repeat kinase 2 (LRRK2) gene are a primary monogenic cause of Parkinson's disease (PD). However, the likelihood of developing PD with inherited LRRK2 pathogenic variants differs (a phenomenon known as "reduced penetrance"), with factors including age and geographic region, highlighting a potential role for lifestyle and environmental factors in disease onset. To investigate this, household dust samples from four different groups of individuals were analyzed using metabolomics/exposomics and metagenomics approaches: PD+/LRRK2+ (PD patients with pathogenic LRRK2 variants; n = 11), PD-/LRRK2+ (individuals with pathogenic LRRK2 variants but without PD diagnosis; n = 8), iPD (PD of unknown cause; n = 11), and a matched, healthy control group (n = 11). The dust was complemented with metabolomics and lipidomics of matched serum samples, where available. A total of 1,003 chemicals and 163 metagenomic operational taxonomic units (mOTUs) were identified in the dust samples, of which ninety chemicals and ten mOTUs were statistically significant (ANOVA p-value < 0.05). Reduced levels of 2-benzothiazolesulfonic acid (BThSO3) were found in the PD-/LRRK2+ group compared to the PD+/LRRK2+ . Among the significant chemicals tentatively identified in dust, two are hazardous chemical replacements: Bisphenol S (BPS), and perfluorobutane sulfonic acid (PFBuS). Furthermore, various lipids were found altered in serum including different lysophosphatidylethanolamines (LPEs), and lysophosphatidylcholines (LPCs), some with higher levels in the PD+/LRRK2+ group compared to the control group. A cellular study on isogenic neurons generated from a PD+/LRRK2+ patient demonstrated that BPS negatively impacts mitochondrial function, which is implicated in PD pathogenesis. This pilot study demonstrates how non-target metabolomics/exposomics analysis of indoor dust samples complemented with metagenomics can prioritize relevant chemicals that may be potential modifiers of LRRK2 penetrance.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Genetic characteristics of leucine-rich repeat kinase 2 (LRRK2) associated Parkinson's disease
    Bardien, Soraya
    Lesage, Suzanne
    Brice, Alexis
    Carr, Jonathan
    PARKINSONISM & RELATED DISORDERS, 2011, 17 (07) : 501 - 508
  • [42] Identification of Blood Serum Micro-RNAs Associated With Idiopathic and LRRK2 Parkinson's Disease
    Botta-Orfila, Teresa
    Morato, Xavier
    Compta, Yaroslau
    Jose Lozano, Juan
    Falgas, Neus
    Valldeoriola, Francesc
    Pont-Sunyer, Claustre
    Vilas, Dolores
    Mengual, Lourdes
    Fernandez, Manel
    Luis Molinuevo, Jose
    Antonell, Anna
    Jose Marti, Maria
    Fernandez-Santiago, Ruben
    Ezquerra, Mario
    JOURNAL OF NEUROSCIENCE RESEARCH, 2014, 92 (08) : 1071 - 1077
  • [43] Clinical characteristics and pathophysiological properties of newly discovered LRRK2 variants associated with Parkinson's disease
    Tezuka, Toshiki
    Ishiguro, Mayu
    Taniguchi, Daisuke
    Osogaguchi, Ehoto
    Shiba-Fukushima, Kahori
    Ogata, Jun
    Ishii, Ryota
    Ikeda, Aya
    Li, Yuanzhe
    Yoshino, Hiroyo
    Matsui, Taro
    Kaida, Kenichi
    Funayama, Manabu
    Nishioka, Kenya
    Kumazawa, Fumihisa
    Matsubara, Tomoyasu
    Tsuda, Hitoshi
    Saito, Yuko
    Murayama, Shigeo
    Imai, Yuzuru
    Hattori, Nobutaka
    NEUROBIOLOGY OF DISEASE, 2024, 199
  • [44] LRRK2 exonic variants are associated with lysosomal hydrolase activities and lysosphingolipid alterations in Parkinson's disease
    Usenko, T. S.
    Senkevich, K. A.
    Basharova, K. S.
    Bezrukova, A. I.
    Baydakova, G. V.
    Tyurin, A. A.
    Beletskaya, M. V.
    Kulabukhova, D. G.
    Grunina, M. N.
    Emelyanov, A. K.
    Miliukhina, I. V.
    Timofeeva, A. A.
    Zakharova, E. Y.
    Pchelina, S. N.
    GENE, 2023, 882
  • [45] LRRK2 p.M1646T is associated with glucocerebrosidase activity and with Parkinson's disease
    Sosero, Yuri L.
    Yu, Eric
    Krohn, Lynne
    Rudakou, Uladzislau
    Mufti, Kheireddin
    Ruskey, Jennifer A.
    Asayesh, Farnaz
    Laurent, Sandra B.
    Spiegelman, Dan
    Fahn, Stanley
    Waters, Cheryl
    Sardi, S. Pablo
    Bandres-Ciga, Sara
    Alcalay, Roy N.
    Gan-Or, Ziv
    Senkevich, Konstantin
    NEUROBIOLOGY OF AGING, 2021, 103 : 142.e1 - 142.e5
  • [46] LRRK2 G2019S Mutations are Associated with an Increased Cancer Risk in Parkinson Disease
    Saunders-Pullman, Rachel
    Barrett, Matthew J.
    Stanley, Kaili M.
    San Luciano, Marta
    Shanker, Vicki
    Severt, Lawrence
    Hunt, Ann
    Raymond, Deborah
    Ozelius, Laurie J.
    Bressman, Susan B.
    MOVEMENT DISORDERS, 2010, 25 (15) : 2536 - 2541
  • [47] A novel P755L mutation in LRRK2 gene associated with Parkinson's disease
    Wu, Ting
    Zeng, Yanying
    Ding, Xinsheng
    Li, Xiaobo
    Li, Wenlei
    Dong, Hairong
    Chen, Senqing
    Zhang, Xiaomei
    Ma, Guojian
    Yao, Juan
    Deng, Xiaoxuan
    NEUROREPORT, 2006, 17 (18) : 1859 - 1862
  • [48] Comparative blood transcriptome analysis in idiopathic and LRRK2 G2019S-associated Parkinson's disease
    Infante, Jon
    Prieto, Carlos
    Sierra, Maria
    Sanchez-Juan, Pascual
    Gonzalez-Aramburu, Isabel
    Sanchez-Quintana, Coro
    Berciano, Jose
    Combarros, Onofre
    Sainz, Jesus
    NEUROBIOLOGY OF AGING, 2016, 38 : 214.e1 - 214.e5
  • [49] Parkinson's Disease Associated with G2019S LRRK2 Mutations without Lewy Body Pathology
    Jackson, Lauren M.
    Woodruff, Bryan K.
    Tremblay, Cecilia
    Shill, Holly A.
    Beach, Thomas G.
    Serrano, Geidy E.
    Adler, Charles H.
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2024, 11 (07): : 874 - 878
  • [50] Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
    Linn Streubel-Gallasch
    Veronica Giusti
    Michele Sandre
    Isabella Tessari
    Nicoletta Plotegher
    Elena Giusto
    Anna Masato
    Ludovica Iovino
    Ilaria Battisti
    Giorgio Arrigoni
    Derya Shimshek
    Elisa Greggio
    Marie-Eve Tremblay
    Luigi Bubacco
    Anna Erlandsson
    Laura Civiero
    Molecular Neurobiology, 2021, 58 : 3119 - 3140